Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH2 MYH4 MYH7 MYH8 MYO15A	4.75e-06	38	131	5	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNHD1 MYH2 MYH4 MYH7 MYH8 KIF23 MYO15A	1.28e-05	118	131	7	GO:0003774
GeneOntologyMolecularFunction	bone sialoprotein binding	ANXA2 ANXA2P2	4.27e-05	2	131	2	GO:0044730
GeneOntologyMolecularFunction	ATP-dependent activity	DDX47 DNHD1 MYH2 MYH4 ABCC4 MYH7 MYH8 KIF23 ATP6V0A1 MACF1 SLFN11 MYO15A SLC27A3 HSP90AB3P	5.22e-05	614	131	14	GO:0140657
GeneOntologyMolecularFunction	beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3- sialyltransferase	ST3GAL1 ST3GAL2	1.28e-04	3	131	2	GO:0047288
GeneOntologyMolecularFunction	phospholipase A2 inhibitor activity	ANXA2 ANXA2P2	4.22e-04	5	131	2	GO:0019834
GeneOntologyMolecularFunction	tRNA (cytidine-5-)-methyltransferase activity	NSUN2 TRDMT1	4.22e-04	5	131	2	GO:0016428
GeneOntologyMolecularFunction	NAD+-protein-cysteine ADP-ribosyltransferase activity	TIPARP PARP12	6.30e-04	6	131	2	GO:0140803
GeneOntologyMolecularFunction	glycosyltransferase activity	B3GALNT1 FUT10 ST3GAL1 ST3GAL2 GTDC1 TIPARP POFUT1 PARP12	6.36e-04	288	131	8	GO:0016757
GeneOntologyMolecularFunction	actin filament binding	MYH2 MYH4 MYH7 MYH8 TULP1 MACF1 MYO15A	7.58e-04	227	131	7	GO:0051015
GeneOntologyMolecularFunction	beta-galactoside (CMP) alpha-2,3-sialyltransferase activity	ST3GAL1 ST3GAL2	8.78e-04	7	131	2	GO:0003836
GeneOntologyBiologicalProcess	muscle filament sliding	MYH2 MYH4 MYH7 MYH8	1.83e-06	15	128	4	GO:0030049
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH2 MYH4 MYH7 MYH8	4.05e-06	18	128	4	GO:0033275
GeneOntologyBiologicalProcess	positive regulation of low-density lipoprotein particle receptor binding	ANXA2 ANXA2P2	3.82e-05	2	128	2	GO:1905597
GeneOntologyBiologicalProcess	positive regulation of receptor-mediated endocytosis involved in cholesterol transport	ANXA2 ANXA2P2	1.14e-04	3	128	2	GO:1905602
GeneOntologyBiologicalProcess	negative regulation of low-density lipoprotein particle receptor catabolic process	ANXA2 ANXA2P2	1.14e-04	3	128	2	GO:0032804
GeneOntologyBiologicalProcess	tRNA decay	NSUN2 SLFN11 TRDMT1	1.78e-04	18	128	3	GO:0016078
GeneOntologyBiologicalProcess	positive regulation of low-density lipoprotein particle clearance	ANXA2 ANXA2P2	2.27e-04	4	128	2	GO:1905581
GeneOntologyBiologicalProcess	negative regulation of receptor catabolic process	ANXA2 ANXA2P2	2.27e-04	4	128	2	GO:2000645
GeneOntologyBiologicalProcess	tRNA stabilization	NSUN2 TRDMT1	2.27e-04	4	128	2	GO:0036416
GeneOntologyBiologicalProcess	negative regulation of tRNA metabolic process	NSUN2 TRDMT1	2.27e-04	4	128	2	GO:1903327
GeneOntologyBiologicalProcess	negative regulation of tRNA catabolic process	NSUN2 TRDMT1	2.27e-04	4	128	2	GO:1902371
GeneOntologyBiologicalProcess	positive regulation of intracellular cholesterol transport	ANXA2 ANXA2P2	2.27e-04	4	128	2	GO:0032385
GeneOntologyBiologicalProcess	positive regulation of intracellular sterol transport	ANXA2 ANXA2P2	2.27e-04	4	128	2	GO:0032382
GeneOntologyBiologicalProcess	protein sialylation	ST3GAL1 ST3GAL2	2.27e-04	4	128	2	GO:1990743
GeneOntologyBiologicalProcess	positive regulation of plasma membrane repair	ANXA2 ANXA2P2	3.77e-04	5	128	2	GO:1905686
GeneOntologyBiologicalProcess	regulation of low-density lipoprotein particle receptor binding	ANXA2 ANXA2P2	3.77e-04	5	128	2	GO:1905595
GeneOntologyBiologicalProcess	regulation of tRNA stability	NSUN2 TRDMT1	3.77e-04	5	128	2	GO:0036415
GeneOntologyBiologicalProcess	regulation of tRNA catabolic process	NSUN2 TRDMT1	3.77e-04	5	128	2	GO:1902370
GeneOntologyBiologicalProcess	dermatan sulfate biosynthetic process	UST DSEL	3.77e-04	5	128	2	GO:0030208
GeneOntologyBiologicalProcess	positive regulation of intracellular lipid transport	ANXA2 ANXA2P2	3.77e-04	5	128	2	GO:0032379
GeneOntologyBiologicalProcess	glycoprotein biosynthetic process	B3GALNT1 FUT10 SRD5A3 ST3GAL1 ST3GAL2 UST LIPC POFUT1 DSEL	3.94e-04	357	128	9	GO:0009101
GeneOntologyCellularComponent	muscle myosin complex	MYH2 MYH4 MYH7 MYH8	2.45e-06	16	130	4	GO:0005859
GeneOntologyCellularComponent	myosin filament	MYH2 MYH4 MYH7 MYH8	1.63e-05	25	130	4	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH2 MYH4 MYH7 MYH8	2.60e-05	28	130	4	GO:0016460
GeneOntologyCellularComponent	myosin complex	MYH2 MYH4 MYH7 MYH8 MYO15A	3.29e-05	59	130	5	GO:0016459
GeneOntologyCellularComponent	AnxA2-p11 complex	ANXA2 ANXA2P2	1.15e-04	3	130	2	GO:1990665
GeneOntologyCellularComponent	PCSK9-AnxA2 complex	ANXA2 ANXA2P2	1.15e-04	3	130	2	GO:1990667
GeneOntologyCellularComponent	myelin sheath adaxonal region	ANXA2 ANXA2P2	7.90e-04	7	130	2	GO:0035749
Domain	DHR-1_domain	DOCK11 DOCK9 DOCK5 DOCK6	6.28e-07	11	126	4	IPR027007
Domain	DHR_2	DOCK11 DOCK9 DOCK5 DOCK6	6.28e-07	11	126	4	PS51651
Domain	DHR_1	DOCK11 DOCK9 DOCK5 DOCK6	6.28e-07	11	126	4	PS51650
Domain	DHR-2	DOCK11 DOCK9 DOCK5 DOCK6	6.28e-07	11	126	4	PF06920
Domain	DOCK	DOCK11 DOCK9 DOCK5 DOCK6	6.28e-07	11	126	4	IPR026791
Domain	DOCK_C	DOCK11 DOCK9 DOCK5 DOCK6	6.28e-07	11	126	4	IPR010703
Domain	DOCK-C2	DOCK11 DOCK9 DOCK5 DOCK6	6.28e-07	11	126	4	PF14429
Domain	DHR-2	DOCK11 DOCK9 DOCK5 DOCK6	6.28e-07	11	126	4	IPR027357
Domain	Myosin_N	MYH2 MYH4 MYH7 MYH8	2.54e-06	15	126	4	PF02736
Domain	Myosin_N	MYH2 MYH4 MYH7 MYH8	2.54e-06	15	126	4	IPR004009
Domain	Myosin_head_motor_dom	MYH2 MYH4 MYH7 MYH8 MYO15A	5.42e-06	38	126	5	IPR001609
Domain	MYOSIN_MOTOR	MYH2 MYH4 MYH7 MYH8 MYO15A	5.42e-06	38	126	5	PS51456
Domain	Myosin_head	MYH2 MYH4 MYH7 MYH8 MYO15A	5.42e-06	38	126	5	PF00063
Domain	MYSc	MYH2 MYH4 MYH7 MYH8 MYO15A	5.42e-06	38	126	5	SM00242
Domain	Myosin_tail_1	MYH2 MYH4 MYH7 MYH8	5.62e-06	18	126	4	PF01576
Domain	Myosin_tail	MYH2 MYH4 MYH7 MYH8	5.62e-06	18	126	4	IPR002928
Domain	DUF3398	DOCK11 DOCK9 DOCK6	5.91e-06	6	126	3	PF11878
Domain	DOCK_C/D_N	DOCK11 DOCK9 DOCK6	5.91e-06	6	126	3	IPR021816
Domain	Myosin-like_IQ_dom	MYH2 MYH4 MYH7 MYH8	7.08e-06	19	126	4	IPR027401
Domain	-	MYH2 MYH4 MYH7 MYH8	7.08e-06	19	126	4	4.10.270.10
Domain	-	MOSPD2 CFAP221 HYDIN	1.64e-05	8	126	3	2.60.40.360
Domain	PapD-like	MOSPD2 CFAP221 HYDIN	2.44e-05	9	126	3	IPR008962
Domain	Cadherin_tail	PCDHGA5 PCDHA11 PCDHA5 PCDHA4	1.10e-04	37	126	4	PF15974
Domain	Cadherin_CBD	PCDHGA5 PCDHA11 PCDHA5 PCDHA4	1.10e-04	37	126	4	IPR031904
Domain	-	PAPOLB PAPOLA	1.35e-04	3	126	2	3.30.70.590
Domain	RB_A	RBL1 RBL2	1.35e-04	3	126	2	IPR002720
Domain	DUF3452	RBL1 RBL2	1.35e-04	3	126	2	PF11934
Domain	RB_B	RBL1 RBL2	1.35e-04	3	126	2	IPR002719
Domain	Anion_exchange_CS	SLC4A3 SLC4A2	1.35e-04	3	126	2	IPR018241
Domain	CBF	NOC3L CEBPZ	1.35e-04	3	126	2	PF03914
Domain	RB_C	RBL1 RBL2	1.35e-04	3	126	2	IPR015030
Domain	RB_fam	RBL1 RBL2	1.35e-04	3	126	2	IPR028309
Domain	CCAAT-binding_factor	NOC3L CEBPZ	1.35e-04	3	126	2	IPR005612
Domain	NuclTrfase_I_C	PAPOLB PAPOLA	1.35e-04	3	126	2	IPR011068
Domain	RB_N	RBL1 RBL2	1.35e-04	3	126	2	IPR024599
Domain	PAP_central	PAPOLB PAPOLA	1.35e-04	3	126	2	PF04928
Domain	PAP_RNA-bind	PAPOLB PAPOLA	1.35e-04	3	126	2	PF04926
Domain	PolA_pol_cen_dom	PAPOLB PAPOLA	1.35e-04	3	126	2	IPR007012
Domain	PolA_pol_RNA-bd_dom	PAPOLB PAPOLA	1.35e-04	3	126	2	IPR007010
Domain	RB_A	RBL1 RBL2	1.35e-04	3	126	2	PF01858
Domain	RB_B	RBL1 RBL2	1.35e-04	3	126	2	PF01857
Domain	PolyA_polymerase	PAPOLB PAPOLA	1.35e-04	3	126	2	IPR014492
Domain	DUF3452	RBL1 RBL2	1.35e-04	3	126	2	SM01367
Domain	Rb_C	RBL1 RBL2	1.35e-04	3	126	2	SM01369
Domain	RB_A	RBL1 RBL2	1.35e-04	3	126	2	SM01368
Domain	IQ	MYH2 MYH4 MYH7 MYH8 MYO15A	2.19e-04	81	126	5	SM00015
Domain	IQ_motif_EF-hand-BS	MYH2 MYH4 MYH7 MYH8 MYO15A	3.59e-04	90	126	5	IPR000048
Domain	IQ	MYH2 MYH4 MYH7 MYH8 MYO15A	4.17e-04	93	126	5	PS50096
Domain	Anion_exchange	SLC4A3 SLC4A2	4.46e-04	5	126	2	IPR001717
Domain	ARM-type_fold	DOCK11 DOCK9 NOC3L ITPR2 DOCK5 NCAPG AP2B1 PIK3C2B CEBPZ	4.92e-04	339	126	9	IPR016024
Domain	ANION_EXCHANGER_2	SLC4A3 SLC4A2	9.27e-04	7	126	2	PS00220
Domain	ANION_EXCHANGER_1	SLC4A3 SLC4A2	9.27e-04	7	126	2	PS00219
Domain	Cadherin_2	PCDHGA5 PCDHA11 PCDHA5 PCDHA4	9.73e-04	65	126	4	PF08266
Domain	Cadherin_N	PCDHGA5 PCDHA11 PCDHA5 PCDHA4	9.73e-04	65	126	4	IPR013164
Domain	Neurexophilin	NXPE1 NXPH2	1.23e-03	8	126	2	PF06312
Domain	NXPH/NXPE	NXPE1 NXPH2	1.23e-03	8	126	2	IPR026845
Domain	IQ	MYH2 MYH4 MYH8 MYO15A	1.35e-03	71	126	4	PF00612
Domain	-	SLC4A3 SLC4A2	1.58e-03	9	126	2	3.40.1100.10
Domain	Band3_cytoplasmic_dom	SLC4A3 SLC4A2	1.58e-03	9	126	2	IPR013769
Domain	Band_3_cyto	SLC4A3 SLC4A2	1.58e-03	9	126	2	PF07565
Domain	P-loop_NTPase	DDX47 DNHD1 MYH2 MYH4 ABCC4 MYH7 MYH8 KIF23 UST ARHGAP5 SLFN11 DSEL MYO15A HYDIN	1.75e-03	848	126	14	IPR027417
Domain	PTrfase/Anion_transptr	SLC4A3 SLC4A2	1.96e-03	10	126	2	IPR016152
Domain	HCO3_transpt_euk	SLC4A3 SLC4A2	1.96e-03	10	126	2	IPR003020
Domain	HCO3_cotransp	SLC4A3 SLC4A2	1.96e-03	10	126	2	PF00955
Domain	HCO3_transpt_C	SLC4A3 SLC4A2	1.96e-03	10	126	2	IPR011531
Domain	NTP_transf_2	PAPOLB PAPOLA	2.39e-03	11	126	2	PF01909
Domain	Polymerase_NTP_transf_dom	PAPOLB PAPOLA	2.39e-03	11	126	2	IPR002934
Domain	WWE	TIPARP PARP12	2.85e-03	12	126	2	PF02825
Domain	WWE-dom	TIPARP PARP12	2.85e-03	12	126	2	IPR004170
Domain	WWE	TIPARP PARP12	2.85e-03	12	126	2	PS50918
Domain	SH3_domain	MIA3 FNBP1L DOCK5 MACF1 MYO15A ZNF582	3.81e-03	220	126	6	IPR001452
Domain	Sialyl_trans	ST3GAL1 ST3GAL2	4.48e-03	15	126	2	IPR012163
Domain	OAR	ALX4 ALX1	4.48e-03	15	126	2	PF03826
Domain	OAR	ALX4 ALX1	5.09e-03	16	126	2	PS50803
Domain	OAR_dom	ALX4 ALX1	5.09e-03	16	126	2	IPR003654
Domain	Poly(ADP-ribose)pol_cat_dom	TIPARP PARP12	5.75e-03	17	126	2	IPR012317
Domain	PARP_CATALYTIC	TIPARP PARP12	5.75e-03	17	126	2	PS51059
Domain	PARP	TIPARP PARP12	5.75e-03	17	126	2	PF00644
Domain	-	TIPARP PARP12	5.75e-03	17	126	2	3.90.228.10
Domain	Cadherin_CS	PCDHGA5 PCDHA11 PCDHA5 PCDHA4	6.37e-03	109	126	4	IPR020894
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH2 MYH4 MYH7 MYH8	9.58e-10	5	131	4	12919077
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH2 MYH4 MYH7 MYH8	2.87e-09	6	131	4	1728586
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH2 MYH4 MYH7 MYH8	2.87e-09	6	131	4	10588881
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH2 MYH4 MYH7 MYH8	6.67e-09	7	131	4	35210422
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH2 MYH4 MYH7 MYH8	6.67e-09	7	131	4	16819597
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH2 MYH4 MYH7 MYH8	1.34e-07	13	131	4	8404542
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH2 MYH4 MYH7 MYH8	1.87e-07	14	131	4	27184118
Pubmed	Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.	DOCK11 DOCK9 DOCK5 DOCK6	1.87e-07	14	131	4	12432077
Pubmed	Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H.	MYH2 MYH4 MYH7 MYH8	4.40e-07	17	131	4	16124007
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH2 MYH4 MYH8	5.19e-07	5	131	3	3829126
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH2 MYH4 MYH8	5.19e-07	5	131	3	6196357
Pubmed	ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.	B3GALNT1 ABCC4 MIA3 ATP6V0A1 MOSPD2 RTN3 ST3GAL1 ST3GAL2 HACD2 UST TXNDC11 SLC4A2 SACM1L ITPR2 MET POFUT1 DSEL SLC27A3	6.40e-07	1201	131	18	35696571
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH2 MYH4 MYH8	1.04e-06	6	131	3	10077619
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH2 MYH4 MYH7	1.81e-06	7	131	3	29758057
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH2 MYH4 MYH7	2.88e-06	8	131	3	26993635
Pubmed	Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene.	MYH4 MYH7 MYH8	2.88e-06	8	131	3	3864153
Pubmed	GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics.	MYH2 MYH4 MYH7	4.31e-06	9	131	3	31960486
Pubmed	Molecular mechanisms governing Pcdh-gamma gene expression: evidence for a multiple promoter and cis-alternative splicing model.	PCDHA11 PCDHA5 PCDHA4	4.31e-06	9	131	3	12154121
Pubmed	The expression of myosin genes in developing skeletal muscle in the mouse embryo.	MYH4 MYH7 MYH8	6.15e-06	10	131	3	2211821
Pubmed	Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development.	MYH2 MYH4 MYH7 MYH8	7.23e-06	33	131	4	32094117
Pubmed	CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function.	MYH2 MYH4 MYH7	8.43e-06	11	131	3	30962377
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH2 MYH4 MYH7	8.43e-06	11	131	3	18310078
Pubmed	Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex.	PCDHA11 PCDHA5 PCDHA4	8.43e-06	11	131	3	9655502
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH2 MYH4 MYH8	8.43e-06	11	131	3	8136524
Pubmed	Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.	MYH2 MYH4 MYH7	8.43e-06	11	131	3	16024798
Pubmed	Ephrin-A3 promotes and maintains slow muscle fiber identity during postnatal development and reinnervation.	MYH2 MYH4 MYH7	8.43e-06	11	131	3	26644518
Pubmed	The histone code reader Spin1 controls skeletal muscle development.	MYH2 MYH4 MYH7	8.43e-06	11	131	3	29168801
Pubmed	Proteins of the CNR family are multiple receptors for Reelin.	PCDHA11 PCDHA5 PCDHA4	1.12e-05	12	131	3	10612399
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	EXOC6 MIA3 ATP6V0A1 NOC3L RTN3 HACD2 NSUN2 SLC4A2 SACM1L YIF1A NCAPG CEBPZ POFUT1 SLC27A3	1.35e-05	942	131	14	31073040
Pubmed	Regulation of spermatogenesis by testis-specific, cytoplasmic poly(A) polymerase TPAP.	PAPOLB PAPOLA	1.41e-05	2	131	2	12471261
Pubmed	Length-dependent effects on cardiac contractile dynamics are different in cardiac muscle containing α- or β-myosin heavy chain.	MYH4 MYH7	1.41e-05	2	131	2	23111184
Pubmed	Vascular endothelial growth factor upregulates expression of annexin A2 in vitro and in a mouse model of ischemic retinopathy.	ANXA2 ANXA2P2	1.41e-05	2	131	2	19536308
Pubmed	Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate.	ANXA2 ANXA2P2	1.41e-05	2	131	2	23148505
Pubmed	Early expression of p107 is associated with 3T3-L1 adipocyte differentiation.	RBL1 RBL2	1.41e-05	2	131	2	12242027
Pubmed	ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.	ANXA2 ANXA2P2	1.41e-05	2	131	2	38290972
Pubmed	The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin I heavy chain) reveals a multidomain protein with internal repeats.	ANXA2 ANXA2P2	1.41e-05	2	131	2	3013423
Pubmed	Activation of Annexin A2 signaling at the blood-brain barrier in a mouse model of multiple sclerosis.	ANXA2 ANXA2P2	1.41e-05	2	131	2	35064931
Pubmed	Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans.	ANXA2 ANXA2P2	1.41e-05	2	131	2	28130864
Pubmed	RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis.	NSUN2 TRDMT1	1.41e-05	2	131	2	22885326
Pubmed	Shared role of the pRB-related p130 and p107 proteins in limb development.	RBL1 RBL2	1.41e-05	2	131	2	8682294
Pubmed	Vascular ligation response is independent of p107: stressing the role of the related p130.	RBL1 RBL2	1.41e-05	2	131	2	12860570
Pubmed	Localization of annexin II in the paranodal regions and Schmidt-Lanterman incisures in the peripheral nervous system.	ANXA2 ANXA2P2	1.41e-05	2	131	2	17549680
Pubmed	Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo.	CPB2 C5	1.41e-05	2	131	2	17105819
Pubmed	Annexin A2 promotes proliferative vitreoretinopathy in response to a macrophage inflammatory signal in mice.	ANXA2 ANXA2P2	1.41e-05	2	131	2	39384746
Pubmed	Annexin A2 mediates up-regulation of NF-κB, β-catenin, and stem cell in response to progastrin in mice and HEK-293 cells.	ANXA2 ANXA2P2	1.41e-05	2	131	2	20826156
Pubmed	Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue.	ANXA2 ANXA2P2	1.41e-05	2	131	2	27468426
Pubmed	Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.	ANXA2 ANXA2P2	1.41e-05	2	131	2	19841537
Pubmed	In vivo expression of HGF/NK1 and GLP-1 From dsAAV vectors enhances pancreatic ß-cell proliferation and improves pathology in the db/db mouse model of diabetes.	LEPR MET	1.41e-05	2	131	2	20841608
Pubmed	Annexin A2 Modulates ROS and Impacts Inflammatory Response via IL-17 Signaling in Polymicrobial Sepsis Mice.	ANXA2 ANXA2P2	1.41e-05	2	131	2	27389701
Pubmed	Annexin II expressed by osteoblasts and endothelial cells regulates stem cell adhesion, homing, and engraftment following transplantation.	ANXA2 ANXA2P2	1.41e-05	2	131	2	17360942
Pubmed	Annexin A2 regulates phagocytosis of photoreceptor outer segments in the mouse retina.	ANXA2 ANXA2P2	1.41e-05	2	131	2	19587120
Pubmed	Loss of the mammalian DREAM complex deregulates chondrocyte proliferation.	RBL1 RBL2	1.41e-05	2	131	2	24710275
Pubmed	Annexin A2 at the interface between F-actin and membranes enriched in phosphatidylinositol 4,5,-bisphosphate.	ANXA2 ANXA2P2	1.41e-05	2	131	2	19022301
Pubmed	Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells.	RBL1 RBL2	1.41e-05	2	131	2	16537896
Pubmed	Multi-Omics Profiling Identifies Microglial Annexin A2 as a Key Mediator of NF-κB Pro-inflammatory Signaling in Ischemic Reperfusion Injury.	ANXA2 ANXA2P2	1.41e-05	2	131	2	38253182
Pubmed	Effects of bone fracture and surgery on plasma myosin heavy chain fragments of skeletal muscle.	MYH2 MYH7	1.41e-05	2	131	2	10579056
Pubmed	Expression of the retinoblastoma-related p107 and Rb2/p130 genes in human placenta: an immunohistochemical study.	RBL1 RBL2	1.41e-05	2	131	2	11642725
Pubmed	Annexin A2 is a novel cellular redox regulatory protein involved in tumorigenesis.	ANXA2 ANXA2P2	1.41e-05	2	131	2	22185818
Pubmed	Loss of gene function as a consequence of human papillomavirus DNA integration.	CASZ1 LIPC	1.41e-05	2	131	2	22262398
Pubmed	A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.	ANXA2 ANXA2P2	1.41e-05	2	131	2	21486955
Pubmed	FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest.	RBL1 RBL2	1.41e-05	2	131	2	12177046
Pubmed	Lipid raft endocytosis and exosomal transport facilitate extracellular trafficking of annexin A2.	ANXA2 ANXA2P2	1.41e-05	2	131	2	21737841
Pubmed	The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.	RBL1 RBL2	1.41e-05	2	131	2	16381817
Pubmed	Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins.	RBL1 RBL2	1.41e-05	2	131	2	28289097
Pubmed	Regulation of the low-dose radiation paracrine-specific anchorage-independent growth response by annexin A2.	ANXA2 ANXA2P2	1.41e-05	2	131	2	19580511
Pubmed	Human intestinal anion exchanger isoforms: expression, distribution, and membrane localization.	SLC4A3 SLC4A2	1.41e-05	2	131	2	11248201
Pubmed	Expression of p107 and p130 during human adipose-derived stem cell adipogenesis.	RBL1 RBL2	1.41e-05	2	131	2	18086563
Pubmed	Five skeletal myosin heavy chain genes are organized as a multigene complex in the human genome.	MYH4 MYH8	1.41e-05	2	131	2	8518795
Pubmed	Selenomethionine promotes ANXA2 phosphorylation for proliferation and protein synthesis of myoblasts and skeletal muscle growth.	ANXA2 ANXA2P2	1.41e-05	2	131	2	36739096
Pubmed	Methionine-induced hyperhomocysteinemia reverts fibrinolytic pathway activation in a murine model of acute promyelocytic leukemia.	ANXA2 ANXA2P2	1.41e-05	2	131	2	22517898
Pubmed	Anxa2 gene silencing attenuates obesity-induced insulin resistance by suppressing the NF-κB signaling pathway.	ANXA2 ANXA2P2	1.41e-05	2	131	2	30462534
Pubmed	Distinct roles for p107 and p130 in Rb-independent cellular senescence.	RBL1 RBL2	1.41e-05	2	131	2	18418057
Pubmed	Differential expression and functionally co-operative roles for the retinoblastoma family of proteins in epidermal differentiation.	RBL1 RBL2	1.41e-05	2	131	2	9747874
Pubmed	Inhibition of the membrane repair protein annexin-A2 prevents tumor invasion and metastasis.	ANXA2 ANXA2P2	1.41e-05	2	131	2	38092984
Pubmed	Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancer.	ANXA2 ANXA2P2	1.41e-05	2	131	2	21572519
Pubmed	Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.	ANXA2 ANXA2P2	1.41e-05	2	131	2	21788340
Pubmed	The Membrane Phospholipid Binding Protein Annexin A2 Promotes Phagocytosis and Nonlytic Exocytosis of Cryptococcus neoformans and Impacts Survival in Fungal Infection.	ANXA2 ANXA2P2	1.41e-05	2	131	2	27371724
Pubmed	Overlapping and unique substrate specificities of ST3GAL1 and 2 during hematopoietic and megakaryocytic differentiation.	ST3GAL1 ST3GAL2	1.41e-05	2	131	2	35507766
Pubmed	Annexin A2 Deficiency Exacerbates Neuroinflammation and Long-Term Neurological Deficits after Traumatic Brain Injury in Mice.	ANXA2 ANXA2P2	1.41e-05	2	131	2	31817350
Pubmed	ANNEXIN A2 FACILITATES NEOVASCULARIZATION TO PROTECT AGAINST MYOCARDIAL INFARCTION INJURY VIA INTERACTING WITH MACROPHAGE YAP AND ENDOTHELIAL INTEGRIN Β3.	ANXA2 ANXA2P2	1.41e-05	2	131	2	37832154
Pubmed	Cell-surface translocation of annexin A2 contributes to bleomycin-induced pulmonary fibrosis by mediating inflammatory response in mice.	ANXA2 ANXA2P2	1.41e-05	2	131	2	30902828
Pubmed	Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis.	ANXA2 ANXA2P2	1.41e-05	2	131	2	24742684
Pubmed	Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections.	ANXA2 ANXA2P2	1.41e-05	2	131	2	32687500
Pubmed	Temporal spatial expression and function of non-muscle myosin II isoforms IIA and IIB in scar remodeling.	MYH2 MYH4	1.41e-05	2	131	2	21102503
Pubmed	Annexin A2 binds to endosomes following organelle destabilization by particulate wear debris.	ANXA2 ANXA2P2	1.41e-05	2	131	2	22453828
Pubmed	p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB.	RBL1 RBL2	1.41e-05	2	131	2	9418868
Pubmed	Agents that bind annexin A2 suppress ocular neovascularization.	ANXA2 ANXA2P2	1.41e-05	2	131	2	20607799
Pubmed	A new role for host annexin A2 in establishing bacterial adhesion to vascular endothelial cells: lines of evidence from atomic force microscopy and an in vivo study.	ANXA2 ANXA2P2	1.41e-05	2	131	2	31253864
Pubmed	Dedicator of Cytokinesis 5 Regulates Keratinocyte Function and Promotes Diabetic Wound Healing.	LEPR DOCK5	1.41e-05	2	131	2	33627322
Pubmed	Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.	ANXA2 ANXA2P2	1.41e-05	2	131	2	19628708
Pubmed	Annexin A2 binds to the localization signal in the 3' untranslated region of c-myc mRNA.	ANXA2 ANXA2P2	1.41e-05	2	131	2	15654879
Pubmed	cDNA cloning and tissue distribution of mRNAs for two proteins that are related to the band 3 Cl-/HCO3- exchanger.	SLC4A3 SLC4A2	1.41e-05	2	131	2	2294114
Pubmed	Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis.	ANXA2 ANXA2P2	1.41e-05	2	131	2	20847146
Pubmed	Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease.	MYH2 MYH4 MYH8 MED23	1.43e-05	39	131	4	38690566
Pubmed	Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation.	MYH2 MYH4 MYH7	1.84e-05	14	131	3	33742095
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH2 MYH4 MYH7	1.84e-05	14	131	3	24938781
Pubmed	Calcium-binding protein 7 expressed in muscle negatively regulates age-related degeneration of neuromuscular junctions in mice.	MYH2 MYH4 MYH7	1.84e-05	14	131	3	38327785
Pubmed	skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration.	MYH2 MYH4 MYH7	1.84e-05	14	131	3	21071677
Pubmed	Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons.	PCDHA11 PCDHA5 PCDHA4	2.30e-05	15	131	3	15640798
Pubmed	Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype.	MYH2 MYH4 MYH7	2.30e-05	15	131	3	24852826
Cytoband	1p36.22	PEX14 CASZ1 VPS13D	1.64e-04	37	131	3	1p36.22
Cytoband	5q31	PCDHGA5 PCDHA11 PCDHA5 PCDHA4	3.43e-04	115	131	4	5q31
GeneFamily	Myosin heavy chains	MYH2 MYH4 MYH7 MYH8	6.86e-07	15	88	4	1098
GeneFamily	Clustered protocadherins	PCDHGA5 PCDHA11 PCDHA5 PCDHA4	2.66e-04	64	88	4	20
GeneFamily	Fucosyltransferases\|Blood group antigens	FUT10 POFUT1	1.76e-03	13	88	2	434
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.PolyIC.Lu, CD45 MHCII CD11c CD103 CD11b, Lung, avg-3	TTC39B ATP6V0A1 MOSPD2 ANXA2 FNBP1L TIPARP DOCK5 MET ARHGAP5 TRIB1 PARP12	1.72e-05	384	125	11	GSM605820_500
CoexpressionAtlas	Myeloid Cells, DC.103+11b-.Lv, CD45+ CD11c+ MHC-II+ CD11b low CD103+, Liver, avg-2	KIF23 MOSPD2 FNBP1L UST CDC14A TIPARP DOCK5 MET ARHGAP5 NCAPG TRIB1	3.08e-05	409	125	11	GSM538234_500
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TTC39B ABCC4 ST3GAL1 UST CASZ1 ITPR2 NXPH2	8.22e-07	173	131	7	0bc2aacae60c6d3276b0949eb0748b4ac1f56e54
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TTC39B ABCC4 ST3GAL1 UST CASZ1 ITPR2 NXPH2	9.23e-07	176	131	7	c2c4306476989bc2fb30dab00250ef7915842f13
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 ARSJ FNBP1L UST CASZ1 ITPR2 NXPH2	1.43e-06	188	131	7	e751cff2ac8fbc1487766c1871fcc5d1005286b0
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARSJ FNBP1L UST CDC14A ITPR2 GABRA5	1.20e-05	172	131	6	adc09c4d1b63fe84150516beb692db1e7f7ac980
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 ST3GAL1 UST CASZ1 ITPR2 NXPH2	1.33e-05	175	131	6	1d8da48236549c01381f777ce5b2937f9f86acc2
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NOC3L KIAA1586 SACM1L FRMD4A C5 DOCK6	1.37e-05	176	131	6	30adf8f1638c6244586f8101c2590bb964dfae00
ToppCell	3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NOC3L KIAA1586 SACM1L FRMD4A C5 DOCK6	1.37e-05	176	131	6	23fa02d4c39e0b8faa1658116d50b6233a952ccc
ToppCell	droplet-Heart-nan-3m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EXOC6 MOSPD2 FNBP1L ITPR2 ARHGAP5 PIK3C2B	1.61e-05	181	131	6	92d44892bb15771f0ab5fe61879b204b0acbd9b3
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PEX14 ST3GAL2 HACD2 SLC4A2 USP38 NSMAF	1.76e-05	184	131	6	2c2125b8030af83f7a6d59a7102d4de8e0ac1988
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Otof_(Layer_2/3)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	MOXD2P ARSJ C12orf56 TEX29	1.80e-05	53	131	4	a41f66edf468f824494a922c3addf429a9125b7f
ToppCell	droplet-Liver-LIVER_HEP-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FUT10 DENND2D TUBGCP6 UNC5A PIK3C2B DOCK6	1.82e-05	185	131	6	bdd2e6cb20294b39a9d856004bf57ba69cf877e2
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ABCC4 ARSJ UST CASZ1 ITPR2 NXPH2	1.88e-05	186	131	6	a6ef5d5944af5689b5f27bef89cd05645eedbe50
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MOSPD2 FNBP1L ITPR2 ARHGAP5 PIK3C2B DOCK6	1.88e-05	186	131	6	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	Nasal_Brush-Immune-Neutrophils\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	TRPM7 RBL2 GDAP2 KIAA1586 CASZ1 CFAP221	1.88e-05	186	131	6	f5aa91dbef29f7efa2b9a728c6539d7541340cd4
ToppCell	COPD-Endothelial-VE_Arterial\|Endothelial / Disease state, Lineage and Cell class	EXOC6 ABCC4 LEPR TIPARP ITPR2 MET	2.18e-05	191	131	6	ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCell	Control-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	ABCC4 ATP6V0A1 DOCK9 UST MACF1 TRIB1	2.38e-05	194	131	6	a01de094f7bfd099bcbb2f94224690a2efb887b4
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NOC3L DENND2D ALX4 MED23 TRIB1	2.40e-05	116	131	5	f2bf9599040f43b5ea8724841d7b71c0a859c016
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ABCC4 ARSJ ST3GAL1 MET C5 DSEL	2.59e-05	197	131	6	1a1bee8da6e04b65935c40373eaee4d6c046d9a1
ToppCell	kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	EXOC6 ANXA2 DOCK9 GLYATL2 LEPR PIK3C2B	2.74e-05	199	131	6	a3ec743b978ba8fdf1677b4971b5731f50ddd30f
ToppCell	LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ARSJ ANXA2 ST3GAL1 MET C5 DSEL	2.74e-05	199	131	6	0447f8f53389fe7c6ddc04a97d86e74122ea16f4
Drug	Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A	RBL1 NOC3L PEX14 ST3GAL2 VPS13D NCAPG PIK3C2B TRAPPC10 TMEM63A	1.41e-06	190	129	9	2619_DN
Drug	Prednisolone [50-24-8]; Up 200; 11uM; MCF7; HT_HG-U133A	ATP6V0A1 DOCK9 PEX14 LEPR MET POFUT1 PARP12 TRDMT1 TMEM63A	2.06e-06	199	129	9	5526_UP
Drug	formycin triphosphate	MYH2 MYH4 MYH7 MYH8 MYO15A	1.03e-05	51	129	5	CID000122274
Drug	Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	DOCK9 CDC14A LEPR DOCK5 MET PAPOLA POFUT1 DOCK6	1.64e-05	196	129	8	2288_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A	ATP6V0A1 VPS13D LDB1 PAPOLA DOCK6 SMAD4 TRDMT1 TMEM63A	1.83e-05	199	129	8	3608_DN
Drug	Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A	ATP6V0A1 GTDC1 UST CDC14A DOCK5 MET PAPOLA POFUT1	1.83e-05	199	129	8	1699_UP
Drug	Nystatine [1400-61-9]; Down 200; 4.4uM; MCF7; HT_HG-U133A	B3GALNT1 DOCK9 ST3GAL2 PIK3C2B POFUT1 MED23 SMAD4 TMEM63A	1.89e-05	200	129	8	4807_DN
Drug	Pentetic acid [67-43-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A	GPR85 PCDHA5 LEPR MET FRMD4A POFUT1 C5 TMEM63A	1.89e-05	200	129	8	5264_DN
Drug	purealin	MYH2 MYH4 MYH7 MYH8 MYO15A	1.95e-05	58	129	5	CID006419303
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	6.12e-08	10	124	4	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	6.12e-08	10	124	4	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	6.12e-08	10	124	4	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	6.12e-08	10	124	4	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	6.12e-08	10	124	4	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	6.12e-08	10	124	4	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	6.12e-08	10	124	4	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	6.12e-08	10	124	4	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	1.43e-07	12	124	4	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	1.43e-07	12	124	4	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	2.06e-07	13	124	4	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	3.91e-07	15	124	4	DOID:0050646 (implicated_via_orthology)
Disease	high density lipoprotein particle size measurement	TTC39B TULP1 LIPC NUDT3 DOCK6 TRIB1 BANK1	7.96e-06	170	124	7	EFO_0008592
Disease	phospholipids in large HDL measurement	TTC39B LIPC DOCK6 TRIB1 BANK1	1.44e-05	73	124	5	EFO_0022190
Disease	total lipids in large HDL	TTC39B LIPC DOCK6 TRIB1 BANK1	1.54e-05	74	124	5	EFO_0022189
Disease	free cholesterol in large HDL measurement	TTC39B LIPC DOCK6 TRIB1 BANK1	2.12e-05	79	124	5	EFO_0022157
Disease	cholesterol in large HDL measurement	TTC39B LIPC DOCK6 TRIB1 BANK1	2.26e-05	80	124	5	EFO_0021900
Disease	lipoprotein measurement, phospholipid measurement	TTC39B LEPR LIPC DOCK6 TRIB1	3.03e-05	85	124	5	EFO_0004639, EFO_0004732
Disease	lipid measurement, lipoprotein measurement	TTC39B LEPR LIPC DOCK6 TRIB1	3.99e-05	90	124	5	EFO_0004529, EFO_0004732
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	TTC39B TULP1 LIPC NUDT3 MACF1 DOCK6 TRIB1 BANK1	4.86e-05	307	124	8	EFO_0004612, EFO_0020946
Disease	myopathy (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	5.01e-05	48	124	4	DOID:423 (implicated_via_orthology)
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	TTC39B FNBP1L LEPR TULP1 LIPC NUDT3 DOCK6 TRIB1	5.44e-05	312	124	8	EFO_0004612, EFO_0010351
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	TTC39B FNBP1L LEPR TULP1 LIPC NUDT3 DOCK6 TRIB1	5.82e-05	315	124	8	EFO_0004574, EFO_0004612
Disease	cholesteryl esters to total lipids in IDL percentage	LIPC MACF1 TRIB1 BANK1	5.89e-05	50	124	4	EFO_0022247
Disease	lipoprotein measurement	TTC39B LEPR LIPC DOCK6 TRIB1	8.34e-05	105	124	5	EFO_0004732
Disease	free cholesterol to total lipids in very large HDL percentage	TTC39B LIPC DOCK6 TRIB1	8.58e-05	55	124	4	EFO_0022288
Disease	cholesterol to total lipids in IDL percentage	LIPC MACF1 TRIB1 BANK1	1.21e-04	60	124	4	EFO_0022233
Disease	sleep duration, high density lipoprotein cholesterol measurement	TTC39B LIPC MACF1 DOCK6 TRIB1	1.63e-04	121	124	5	EFO_0004612, EFO_0005271
Disease	hyperinsulinism (implicated_via_orthology)	LEPR LIPC	1.74e-04	5	124	2	DOID:2018 (implicated_via_orthology)
Disease	Frontonasal dysplasia	ALX4 ALX1	1.74e-04	5	124	2	C1876203
Disease	total lipids in very large HDL measurement	TTC39B LIPC TRIB1 BANK1	1.75e-04	66	124	4	EFO_0022312
Disease	phospholipids in very large HDL measurement	TTC39B LIPC TRIB1 BANK1	1.75e-04	66	124	4	EFO_0022298
Disease	cholesterol in very large HDL measurement	TTC39B LIPC TRIB1 BANK1	2.08e-04	69	124	4	EFO_0022229
Disease	esterified cholesterol measurement	TTC39B LEPR LIPC DOCK6 TRIB1	2.12e-04	128	124	5	EFO_0008589
Disease	choline measurement	TTC39B LEPR LIPC DOCK6 TRIB1	2.27e-04	130	124	5	EFO_0010116
Disease	cardiomyopathy (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	2.32e-04	71	124	4	DOID:0050700 (implicated_via_orthology)
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	TTC39B LEPR LIPC MACF1 DOCK6 TRIB1 BANK1	2.38e-04	291	124	7	EFO_0008317, EFO_0020946
Disease	1,5 anhydroglucitol measurement	PCDHA11 PCDHA5 PCDHA4	2.44e-04	29	124	3	EFO_0008009
Disease	free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	TTC39B FNBP1L TULP1 LIPC DOCK6 TRIB1 BANK1	3.04e-04	303	124	7	EFO_0004612, EFO_0020945
Disease	phospholipid measurement	TTC39B LEPR LIPC DOCK6 TRIB1	3.20e-04	140	124	5	EFO_0004639
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH2 MYH4 MYH7 MYH8	3.67e-04	80	124	4	DOID:12930 (implicated_via_orthology)
Disease	phospholipids:total lipids ratio	TTC39B LIPC MACF1 DOCK6 TRIB1 BANK1	4.07e-04	227	124	6	EFO_0020946
Disease	free cholesterol in small HDL measurement	LIPC DOCK6 TRIB1	4.30e-04	35	124	3	EFO_0022270
Disease	low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	EXOC6 TTC39B LIPC DOCK6 TRIB1	4.81e-04	153	124	5	EFO_0004611, EFO_0020946
Disease	low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	EXOC6 TTC39B LIPC DOCK6 TRIB1	4.81e-04	153	124	5	EFO_0004611, EFO_0020944
Disease	NEPHRONOPHTHISIS 2	TTC21B NXPH2	4.82e-04	8	124	2	C1865872
Disease	Cognition Disorders	ABCC4 MET SMAD4	5.49e-04	38	124	3	C0009241
Disease	cholesteryl ester measurement	EXOC6 TTC39B LIPC DOCK6 TRIB1 BANK1	7.81e-04	257	124	6	EFO_0010351
Disease	1-stearoyl-GPE (18:0) measurement	LIPC TRIB1	9.40e-04	11	124	2	EFO_0800227
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	LIPC MACF1 TRIB1 BANK1	9.53e-04	103	124	4	EFO_0008595, EFO_0020944
Disease	atrial fibrillation	MYH7 UST CASZ1 ITPR2 NUDT3 BANK1 SMAD4	1.00e-03	371	124	7	EFO_0000275
Disease	total lipids in lipoprotein particles measurement	LIPC DOCK6 TRIB1	1.09e-03	48	124	3	EFO_0022309
Disease	HMG CoA reductase inhibitor use measurement	MIA3 LIPC HERC3 DOCK6 TRIB1	1.24e-03	189	124	5	EFO_0009932
Disease	renal cell carcinoma (biomarker_via_orthology)	ANXA2 ANXA2P2	1.54e-03	14	124	2	DOID:4450 (biomarker_via_orthology)
Disease	triglycerides in very large HDL measurement	TTC39B LIPC TRIB1	1.62e-03	55	124	3	EFO_0022324
Disease	glycoprotein measurement	EXOC6 LEPR TRIB1 HYDIN	1.63e-03	119	124	4	EFO_0004555
Disease	triglycerides in very large VLDL measurement	EXOC6 LIPC TRIB1	1.71e-03	56	124	3	EFO_0022325
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	LIPC MACF1 TRIB1 BANK1	1.73e-03	121	124	4	EFO_0008595, EFO_0020943
Disease	low density lipoprotein triglyceride measurement	LIPC TRIB1	1.77e-03	15	124	2	EFO_0009946
Disease	anemia (implicated_via_orthology)	SLC4A3 SLC4A2	1.77e-03	15	124	2	DOID:2355 (implicated_via_orthology)
Disease	total lipids in medium HDL measurement	TTC39B LIPC DOCK6	1.89e-03	58	124	3	EFO_0022310
Disease	free cholesterol in medium HDL measurement	TTC39B LIPC DOCK6	1.89e-03	58	124	3	EFO_0022267
Disease	cholesterol in medium HDL measurement	TTC39B LIPC DOCK6	1.98e-03	59	124	3	EFO_0021903
Disease	phospholipids in VLDL measurement	EXOC6 LIPC TRIB1	1.98e-03	59	124	3	EFO_0022301
Disease	apolipoprotein B measurement	EXOC6 TTC39B CASZ1 LIPC NCAPG DOCK6 TRIB1 HYDIN NSMAF	1.99e-03	663	124	9	EFO_0004615
Disease	pancreatic ductal carcinoma (is_marker_for)	ANXA2 MET SMAD4	2.18e-03	61	124	3	DOID:3587 (is_marker_for)
Disease	free cholesterol in VLDL measurement	EXOC6 LIPC TRIB1	2.18e-03	61	124	3	EFO_0022276
Disease	free cholesterol in HDL measurement	TTC39B LIPC DOCK6	2.18e-03	61	124	3	EFO_0022264
Disease	phospholipids in HDL measurement	TTC39B LIPC DOCK6	2.18e-03	61	124	3	EFO_0022293
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	TTC39B LEPR LIPC NUDT3 DOCK6 TRIB1	2.20e-03	315	124	6	EFO_0004612, EFO_0008591
Disease	Antibody Deficiency Syndrome	LEPR C5	2.29e-03	17	124	2	C0003257
Disease	Lipidemias	LEPR LIPC	2.29e-03	17	124	2	C1706412
Disease	Hyperlipidemia	LEPR LIPC	2.29e-03	17	124	2	C0020473
Disease	free cholesterol in very large HDL measurement	TTC39B LIPC TRIB1	2.29e-03	62	124	3	EFO_0022273
Disease	polyunsaturated fatty acid measurement	TTC39B LIPC DOCK6 TRIB1	2.31e-03	131	124	4	EFO_0010733
Disease	triglycerides to total lipids in IDL percentage	LIPC TRIB1 BANK1	2.39e-03	63	124	3	EFO_0022329
Disease	total lipids in HDL measurement	TTC39B LIPC DOCK6	2.39e-03	63	124	3	EFO_0022307
Disease	fatty acid measurement	EXOC6 TTC39B FNBP1L LIPC MACF1 DOCK6 TRIB1	2.51e-03	436	124	7	EFO_0005110
Disease	very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio	TTC39B MYH2 LIPC MACF1 TRIB1	2.51e-03	222	124	5	EFO_0008317, EFO_0020943
Disease	neutrophil count, basophil count	PCDHA11 PCDHA5 PCDHA4 LEPR TRIB1	2.61e-03	224	124	5	EFO_0004833, EFO_0005090
Disease	lipid measurement, high density lipoprotein cholesterol measurement	TTC39B LEPR LIPC NUDT3 DOCK6 TRIB1	2.77e-03	330	124	6	EFO_0004529, EFO_0004612
Disease	total lipids in large VLDL	EXOC6 LIPC TRIB1	2.85e-03	67	124	3	EFO_0022175
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	LIPC MACF1 BANK1	2.85e-03	67	124	3	EFO_0008595, EFO_0020946
Disease	hydrocephalus (implicated_via_orthology)	DPCD HYDIN	2.86e-03	19	124	2	DOID:10908 (implicated_via_orthology)
Disease	Deaf Mutism	CDC14A SMAD4	3.17e-03	20	124	2	C4082305
Disease	Deafness, Acquired	CDC14A SMAD4	3.17e-03	20	124	2	C0751068
Disease	Hearing Loss, Extreme	CDC14A SMAD4	3.17e-03	20	124	2	C0086395
Disease	Complete Hearing Loss	CDC14A SMAD4	3.17e-03	20	124	2	C0581883
Disease	Bilateral Deafness	CDC14A SMAD4	3.17e-03	20	124	2	C3665473
Disease	Prelingual Deafness	CDC14A SMAD4	3.17e-03	20	124	2	C0011052
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	TTC39B LIPC MACF1 TRIB1	3.25e-03	144	124	4	EFO_0004611, EFO_0020943
Disease	cholesteryl esters to total lipids in very small VLDL percentage	LIPC TRIB1 BANK1	3.36e-03	71	124	3	EFO_0022259
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	TTC39B MYH2 LIPC MACF1 TRIB1	3.45e-03	239	124	5	EFO_0008317, EFO_0020945
Disease	saturated fatty acids to total fatty acids percentage	LIPC TRIB1	3.49e-03	21	124	2	EFO_0022305
Disease	free cholesterol to total lipids in chylomicrons and extremely large VLDL percentage	LIPC TRIB1	3.49e-03	21	124	2	EFO_0022277
Disease	triglycerides to total lipids in small HDL percentage	LIPC TRIB1 BANK1	3.50e-03	72	124	3	EFO_0022336
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	TTC39B LIPC MACF1 TRIB1	3.75e-03	150	124	4	EFO_0004611, EFO_0020947
Disease	free cholesterol to total lipids in large LDL percentage	MACF1 TRIB1 BANK1	3.78e-03	74	124	3	EFO_0022280
Disease	intellectual disability (implicated_via_orthology)	RBL1 RBL2 NSUN2	3.92e-03	75	124	3	DOID:1059 (implicated_via_orthology)
Disease	Immunologic Deficiency Syndromes	LEPR C5	4.18e-03	23	124	2	C0021051

Protein segments in the cluster

Peptide	Gene	Start	Entry
DFKVRDYPLYHLIKA	TTC21B	556	Q7Z4L5
LTSIFKHEIPYYEFQ	BANK1	311	Q8NDB2
ELEKVFQKTHYPDVY	ALX1	146	Q15699
KVFQKTHYPDVYARE	ALX4	231	Q9H161
EKLQQYYIFIPSKFK	DDX47	236	Q9H0S4
IYETFYKLVKIFQEH	SLC4A2	836	P04920
YKLYKVFTEHPLLPF	SLC4A3	841	P48751
IKVFFVKYNDPIYVK	AP2B1	321	P63010
PSKYDLENVKYLHLF	CASZ1	336	Q86V15
AYFPYFKKHNVTAVV	CDC14A	211	Q9UNH5
YIFKELQKYLPSHAV	AASDH	496	Q4L235
SVPHLQKVFDRYKSY	ANXA2	221	P07355
KKIHFLYLNVAPSRY	DNHD1	291	Q96M86
SVPHLQKVFDRYKSY	ANXA2P2	221	A6NMY6
KPFKVICIYIAFYSV	NXPH2	226	O95156
RHDVPYLFQKYVKES	RIMKLA	181	Q8IXN7
PFKLEKSVDNYYHLL	PCDHGA5	391	Q9Y5G8
IIYNLFHKTVPEFKY	TIPARP	476	Q7Z3E1
HYLYFIVLVKVKDPT	ITPR2	2591	Q14571
RDYHIFYQILSNKKP	MYH7	281	P12883
KLFEHYYQELKIVPE	NSUN2	46	Q08J23
IFDVPLYHFYKVIEV	RBL2	556	Q08999
RAHVSPLFKAKYFYI	PAXIP1	966	Q6ZW49
PSFFQKYKHYIVLLA	PAPOLB	366	Q9NRJ5
KYKRNLKAVYFVHPT	GDAP2	416	Q9NXN4
HVPFKLVSTFKNYYS	PCDHA11	391	Q9Y5I1
KHLVKDFNPYITCYI	PCGF5	6	Q86SE9
ILHKYPTVDVLRFKY	H1-8	81	Q8IZA3
ESVIKNYKRYFPVIF	MAGEA9	136	P43362
ATELYYVLKHPKEAF	LDB1	136	Q86U70
LPEFTIKHYAGKVTY	MYO15A	1696	Q9UKN7
VKKHSQFIGYPITLY	HSP90AB3P	181	Q58FF7
NLKVKHVEYDTFYIP	HERC3	601	Q15034
TKPIFLYIAYQAVHS	ARSJ	256	Q5FYB0
GVKFPPDIYYKIFTH	MFI	76	Q8NCR3
LEVYKATYHFIFAQK	KIAA1109	481	Q2LD37
KTHISYQEYPFKVFP	B3GALNT1	221	O75752
YYVKDIPATLKFFHS	HNMT	146	P50135
YHIFYQITSNKKPDL	MYH8	286	P13535
KIFIDKIYSIYHQPN	KIAA1586	441	Q9HCI6
IKVLQYHKPVQASYF	NUDT3	126	O95989
YHIFYQITSNKKPEL	MYH2	286	Q9UKX2
YYELKVVDKFHIPQE	PDE6A	526	P16499
LPIVKTEFQLLYVYH	MED23	1236	Q9ULK4
AVVYITYHNKRKIFL	KCT2	211	Q8NC54
QSPFKVYHYQFKIQF	LIPC	346	P11150
SVKKYYIHDHFIPIE	LEPR	791	P48357
FHLKRKIGYFVIQTY	GABRA5	251	P31644
KYYSHFLFKVVTKLV	TUBGCP6	1781	Q96RT7
HVPFKLVSTFKNYYS	PCDHA5	391	Q9Y5H7
YFVYLPAKLEKGIHF	TMEM63A	651	O94886
PHIYIQVKEFIYASL	EXOC6	486	Q8TAG9
PVELKALYNQYIHFK	MACF1	346	Q9UPN3
VTHYSFASFIYLKPK	OR10H4	251	Q8NGA5
EKIFHPNKGYIYVVK	PIK3C2B	1376	O00750
FVIFEKHQVYPEYVI	PARP12	661	Q9H0J9
LFEAPNFFQKYKHYI	PAPOLA	361	P51003
ETAKQVYFKRNYPHI	ABCC4	1286	O15439
FPYVALSKTYNVDKH	ALPP	96	P05187
VPKRYFSHFYIISVL	SRD5A3	71	Q9H8P0
SHVPFKLVSTFKNYY	PCDHA4	391	Q9UN74
FRHFKLYKYVFTPQV	CFAP119	206	A1A4V9
FQYDYHDKVKPRKIF	FRMD4A	241	Q9P2Q2
PYLKQHLVKTYFVIN	ADCY2	451	Q08462
YSIIIPFKNVFYHMV	HYDIN	5036	Q4G0P3
AHIQVTYVKPYFDDK	DOCK11	1831	Q5JSL3
YEKAFFTEKYLQEHP	DOCK5	1566	Q9H7D0
VVYHNKSPEFYEEFK	DOCK6	606	Q96HP0
SKYAYIQVTHVIPFF	DOCK9	1861	Q9BZ29
HKHFYVVIPQIYKQL	FNBP1L	201	Q5T0N5
KIHIGSSFEKYPLYV	CPB2	146	Q96IY4
YKLFHKPVITLFNYT	FUT10	156	Q6P4F1
YFRNYFPVKLVKTHD	DGAT2L6	81	Q6ZPD8
YFEVKEYVLPHFSVS	C5	216	P01031
YYKKFSIPDLDRHQL	DPCD	136	Q9BVM2
HSLYYSIEKPLKFFQ	HACD2	71	Q6Y1H2
TLLEFYLKTVFKNYH	IL24	111	Q13007
LVLKERALHKAPYYF	GPR173	46	Q9NS66
QVYFIKEHNVVAPYK	NSMAF	111	Q92636
VKDKTLHRAPYYFLL	GPR85	46	P60893
FYVKDPFYISLHLEI	CRIPAK	431	Q8N1N5
TYKFNFSKLIVVNYP	ETV3L	116	Q6ZN32
ILYFHENQLIYPVKK	GTDC1	86	Q4AE62
YEQLKLHITPEKFYV	SACM1L	6	Q9NTJ5
FFHNLDIDFKYIPYK	DSEL	601	Q8IZU8
QIPVDEVFFHRYYKK	CEBPZ	806	Q03701
QFFVKIVGHYASYIK	DENND2D	381	Q9H6A0
IYYFPKVVKTLKFFD	NXPE1	361	Q8N323
VPYRDSKLTHLFKNY	KIF23	386	Q02241
DPLKFYTHLYKTLFK	NOC3L	576	Q8WTT2
TNLHVSYQKYFKLEP	POFUT1	81	Q9H488
SYQKYFKLEPLQAYH	POFUT1	86	Q9H488
YKFEPKLVYHNETTV	MOXD2P	226	A6NHM9
LYKIKRYQPFSVHKS	CFAP221	581	Q4G0U5
LYKIQFHNVKPEYLD	NIPSNAP1	71	Q9BPW8
ILSKYFDLIYVHNPV	MET	826	P08581
FKVYYPKYLSKIVIF	MOSPD2	171	Q8NHP6
PIVYEKYKTQIDHYV	RTN3	991	O95197
EVYKYNFPHTQLLAK	TRDMT1	41	O14717
YFPKDLIQVVHEYTK	MIA3	96	Q5JRA6
IKEHYFKPYISKLFD	RBL1	266	P28749
YPKHKYEVLFLLGLF	SEC11B	146	P0C7V7
VHKIYPSAYIKVFDL	SMAD4	426	Q13485
QDKILIYHPAFIKYV	ST3GAL1	241	Q11201
KEKVQIYNPAFFKYI	ST3GAL2	251	Q16842
KHFQEYVKRTIPEYV	SLFN11	221	Q7Z7L1
YHIFYQILSNKKPEL	MYH4	286	Q9Y623
KFHPVNYDVFRYVIT	ARHGAP5	1376	Q13017
FGFHQLYKKYLLPLI	PEX14	121	O75381
FLPKYQKVHFKEPYS	CCDC15	631	Q0P6D6
KTVFHEEFIHYLKYV	NCAPG	41	Q9BPX3
FYFIVNKLHEYLPES	C12orf56	376	Q8IXR9
KKYVFQLTHDVYKPF	CNKSR1	466	Q969H4
PTVFVKEKHYLTAFY	PROKR1	311	Q8TCW9
YPSYFLHLDTEKKVF	TULP1	321	O00294
RFLPHYFKGVLSIYK	UST	296	Q9Y2C2
FYEPIVKKHYDNILN	TTC30B	481	Q8N4P2
YVAKKLGLLVFPYTH	YIF1A	101	O95070
KLLKYDHYLVPFTLF	TTC39B	616	Q5VTQ0
VFPIKHYQDKIRPYI	TRIB1	121	Q96RU8
YKHIFPFSLIRYDVT	SLC27A3	451	Q5K4L6
YITLFIEKLPKHRDY	STAMBP	66	O95630
YKYPFEQVVASFLRK	PRELID2	11	Q8N945
YVEVFFPQFKIEKNY	SERPINB7	271	O75635
FPKDTAYVLLYKKQH	USP38	936	Q8NB14
SKLLVSYQEIPFYHI	UNC5A	666	Q6ZN44
KYYVSKIVIHPKYQD	PRSS48	96	Q7RTY5
SRYDTKELFPKQHVY	ZNF582	81	Q96NG8
KCRKQKHFFYFPVIY	TXNDC11	171	Q6PKC3
KKLTYDYKISQHFPR	ZSWIM2	481	Q8NEG5
LFNHIYFKKPLNIYF	ATP6V0A1	556	Q93050
FYEPIVKKHYDNILN	TTC30A	481	Q86WT1
YKKAVPIYIHVFSAL	TEX29	51	Q8N6K0
ISLKPYTYEFKVENF	TRAPPC10	1041	P48553
SKKLPITRKFYAFYH	TRPM7	836	Q96QT4
ITRKFYAFYHAPIVK	TRPM7	841	Q96QT4
IYNPQAIKKVADFFY	VPS13D	636	Q5THJ4
EKYLSQKEIPFYFHV	GLYATL2	246	Q8WU03
SPYTEIHLKKYQIFS	NMI	236	Q13287